These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21885386)

  • 1. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis.
    Hook JL; Arcasoy SM; Zemmel D; Bartels MN; Kawut SM; Lederer DJ
    Eur Respir J; 2012 Feb; 39(2):359-65. PubMed ID: 21885386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
    Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
    Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
    Holland AE; Hill CJ; Glaspole I; Goh N; McDonald CF
    Respir Med; 2012 Mar; 106(3):429-35. PubMed ID: 22182340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
    Zappala CJ; Latsi PI; Nicholson AG; Colby TV; Cramer D; Renzoni EA; Hansell DM; du Bois RM; Wells AU
    Eur Respir J; 2010 Apr; 35(4):830-6. PubMed ID: 19840957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
    Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
    Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study).
    Öztürk A; Kayacan O
    Turk J Med Sci; 2018 Aug; 48(4):826-832. PubMed ID: 30119159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
    Alhamad EH; Masood M; Shaik SA; Arafah M
    Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
    Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
    Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.
    Ryerson CJ; Camp PG; Eves ND; Schaeffer M; Syed N; Dhillon S; Jensen D; Maltais F; O'Donnell DE; Raghavan N; Roman M; Stickland MK; Assayag D; Bourbeau J; Dion G; Fell CD; Hambly N; Johannson KA; Kalluri M; Khalil N; Kolb M; Manganas H; Morán-Mendoza O; Provencher S; Ramesh W; Rolf JD; Wilcox PG; Guenette JA
    Ann Am Thorac Soc; 2016 Sep; 13(9):1640-7. PubMed ID: 27348402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kataoka K; Ogawa T; Watanabe F; Arizono S
    Eur Respir J; 2010 Nov; 36(5):1067-72. PubMed ID: 20413545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.
    Vainshelboim B; Kramer MR; Myers J; Unterman A; Izhakian S; Oliveira J
    Lung; 2019 Feb; 197(1):81-88. PubMed ID: 30600393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis.
    Ryerson CJ; O'Connor D; Dunne JV; Schooley F; Hague CJ; Murphy D; Leipsic J; Wilcox PG
    Chest; 2015 Nov; 148(5):1268-1275. PubMed ID: 25996795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.
    Zhang L; Zhang C; Dong F; Song Q; Chi F; Liu L; Wang Y; Che C
    BMC Pulm Med; 2016 Nov; 16(1):137. PubMed ID: 27809901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.